IN THIS issue of the ARCHIVES, 2 studies offer quite different perspectives on indoor tanning. Carlin et al1 report on the combination of acitretin and commercial tanning beds as an effective and useful therapy for psoriasis in geographic areas without access to physician-directed phototherapy. At the University of Utah Health Sciences Center, 26 patients with psoriasis who attended dermatology clinics were retrospectively surveyed in regard to treatments with acitretin and tanning bed light. Of 26 patients with moderate to severe plaque-type psoriasis, 23 received a follow-up physical examination. Nineteen (83%) of 23 experienced either clearance or new clearance of their psoriasis. The authors also conducted a small prospective study in 17 patients with moderate to severe plaque-type psoriasis. Patients received 25 mg of acitretin per day and 5 to 7 tanning sessions per week for 12 weeks. Of 14 patients who completed the study, Psoriasis Area and Severity Index and National Psoriasis Foundation scores decreased on average 78.6% and 79%, respectively, from baseline. Adverse events were generally mild to moderate.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 18
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.